Advertisement

Das kulturell-biochemische und serologische Verhalten der Cryptococcus-Gruppe

  • H. P. R. Seeliger
Conference paper
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 32)

Zusammenfassung

Seit Entdeckung des Erregers der Cryptococcose durch Busse (24, 25, 26) und Buschke (23) vor rund 65 Jahren (7) ist diese weltweit verbreitete, durch einen Sproßpilz verursachte Krankheit annähernd 500mal beim Menschen nachgewiesen worden [vgl. (37, 42, 66, 111 u. a.)], sporadisch und epizootisch ferner beim Milchvieh sowie vereinzelt beim Affen, Schwein, Pferd, Hund, Katze, Meerschweinchen und bei anderen Tierarten [Zusammenfassung s. (61, 111)].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ajello, L., V. Q. Grant, and M. A. Gutske: The effect of tubercle bacillus concentration procedures on fungi causing pulmonary mycosis. J. Lab. clin. Med. 38, 486–491 (1951).PubMedGoogle Scholar
  2. 2.
    Ajello, L., V. Q. Grant, and M. A. Gutske: Soil as a natural reservoir for human pathogenic fungi. Science 123, 876–879 (1956).PubMedGoogle Scholar
  3. 3.
    Ajello, L., Occurrence of Cryptococcus neoformans in soils. Amer. J. Hyg. 67, 72–77 (1958).PubMedGoogle Scholar
  4. 3a.
    Ajello, L., V. Q. Grant and M. A. Gutske: Use of mineral oil in the maintenance of cultures of fungi pathogenic for humans Arch. Derm. Syph. (Chicago) 63, 747–749 (1951).Google Scholar
  5. 4.
    Arzt, L.: Zur Klinik und Pathologie der SproBpilzerkrankungen. Arch. Derm. Syph. (Berl.) 145, 311–312 (1924).Google Scholar
  6. 5.
    Asohner, M., J. Mager and J. Leibowitz: Production of extracellular starch in cultures of capsulated yeasts. Nature (Lond.) 156, 295 (1945).Google Scholar
  7. 6.
    Asohner, M., and A. Cury: Starch production in the genus Trichosporon. J. Bact. 62, 350–352 (1952).Google Scholar
  8. 7.
    Ashbel, R., and A. Dolb: 60 years discovery of C. neoformans (Sanfelice) Vuillemin (Torula histolytica). Harefuah, 49, 108–113 (1955).PubMedGoogle Scholar
  9. 8.
    Ashner, M., and D. Godinger: An ecological study of yeasts of the genus Cryptococcus. Harefuah 49, 107–108 (1955).PubMedGoogle Scholar
  10. 9.
    Bauer, H: Mikroskopisch-chemischer Nachweis von Glykogen und einigen anderen Polysacchariden. Z. mikr -anat. Forsch. 33, 143–160 (1933).Google Scholar
  11. 10.
    Benham, RH.: Cryptococci–their identification by morphology and serology. J. infect. Dis. 57, 255–274 (1937).Google Scholar
  12. 11.
    Benham, RH.: Cryptococcosis and blastomycosis. Ann. N.Y. Acad. Sci. 50, 1199–1214 (1955).Google Scholar
  13. 12.
    Benham, RH.: The genus Cryptococcus: the present status and criteria for the identification of species. Trans. N.Y. Acad. Sci., Ser. II, 17, 418–429 (1955).Google Scholar
  14. 13.
    Benham, RH.: The genus Cryptococcus. Beet. Rev. 20, 189–196 (1956).Google Scholar
  15. 14.
    Benham, RH.: Cryptococcus neoformans: An ascomycete. Proc. Soc. exp. Biol. (N. Y.) 89, 243–245 (1955).Google Scholar
  16. 15.
    Beijerinck, M. W.: L’auxanographie, ou la méthode de l’hydrodiffusion dans la gelatine appliquée aux recherches microbiologiques. Arch. néerl. Sci. 23, 367–372 (1889).Google Scholar
  17. 16.
    Bieberdorf, F. W.: A study of the growth response of some fungi to various concentrations of isonicotinic acid hydrazide. Antibiot. and Chemother. (Basel) 3, 513–520 (1953).Google Scholar
  18. 17.
    Bocobo, F. C., A. C. Curtis, W. D. Block, E. R. Harrell, E. E. Evans, and R. F. Haines: Evaluation of nitrostyrenes as antifungal agents. Antibiot. and Chemother. (Basel) 6, 385–390 (1956).Google Scholar
  19. 18.
    Brian, P. W., and J. C. McGowan: Viridin: a highly fungistatic substance produced by Trichoderma viride. Nature (Lond.) 156, 144–145 (1945).Google Scholar
  20. 19.
    Brockmann, D. D.: The in vitro effect of atabrine on Cryptococcus neoformans. Amer. J. trop. Med. 28, 295–297 (1948).Google Scholar
  21. 20.
    Brown, R., and E. Hazen: Nystatin and actidione: Two antifungal agents produced by Streptomyces noursei. In Sternberg and Newcomer, Therapy of fungus diseases, p. 164–167. Boston and Toronto: Little, Brown & Comp. 1955.Google Scholar
  22. 21.
    Buell, C. B., and W. H. Weston: Application of the mineral oil conservation method to maintaining collection of fungus cultures. Amer. J. Bot. 34, 555–561 (1947).Google Scholar
  23. 22.
    Burke, R. D., J. H. Swartz, S. S. Chapman, and W. Y. Huang: Mycoticin, a new anti-fungal antibiotic. J. invest. Derm. 23, 163–168 (1957).Google Scholar
  24. 23.
    Buschke, A.: Über eine durch Coccidien hervorgerufene Krankheit des Menschen. Dtsch. med. Wschr. 1895, 14.Google Scholar
  25. 24.
    Busse, O.: Über parasitäre Zelleinschlüsse und ihre Züchtung. Zbl. Bakt., I. Abt. Orig. 16, 175–180 (1894).Google Scholar
  26. 25.
    Busse, O.: Über Saccharomycosis hominis. Virchows Arch. path. Anat. 140, 23–46 (1895).Google Scholar
  27. 26.
    Busse, O.: Experimentelle Untersuchungen über Saccharomycosis. Virchows Arch. path. Anat. 144, 360–372 (1896).Google Scholar
  28. 27.
    Caldwell, D. C., and S. S. Raphael: A case of cryptococcal meningitis. J. clin. Path. 8, 32–37 (1955).PubMedGoogle Scholar
  29. 28.
    Carson, L. E., and C. C. Campbell: The inhibition effect of three antihistaminic compounds on the growth of fungi pathogenic for man. Science 111, 689–691 (1950).PubMedGoogle Scholar
  30. 29.
    Carter, A. S., and J. L. Young: Note on the isolation of Cryptococcus neoformans from a sample of milk J Path. Beet. 62, 271 (1950).Google Scholar
  31. 30.
    Carvajal, F.: Fluvomycin: an antibiotic effective against pathogenic bacteria and fungi. Antibiot. and Chemother. (Basel) 3, 765–772 (1953).Google Scholar
  32. 31.
    Carton, C. A.: Treatment of central nervous system cryptococcosis; a review and report of four cases treated with actidione. Ann. intern. Med. 37, 123–154 (1952).PubMedGoogle Scholar
  33. 32.
    Carton, C. A., and CH. S. Liebig: Treatment of central nervous system cryptococcosis; laboratory studies. Arch. intern. Med. 91, 773–783 (1953).Google Scholar
  34. 33.
    Christensen, W. B.: Urea decomposition as a means of differentiating Proteus and Paracolon cultures from each other and from Salmonella and Shigella types. J. Bact. 52, 461–466 (1946).PubMedGoogle Scholar
  35. 34.
    Christison, J. G., N. F. Conant, and C. K. Bradsher: The sensitivity of Histoplasma capsulatum to rhodanine and related compounds. In Sternberg and Newcomer, Therapy of fungus diseases, p. 268–278. Boston and Toronto: Little, Brown & Comp. 1955.Google Scholar
  36. 35.
    Ciferri, R.: Studi sulli torulopsidaceae. Atti Ist. Bot. Univ. Pisa, Ser. Iii 2, 147–301 (1925).Google Scholar
  37. 36.
    Ciferri, R.: A neglected definition of the genus Cryptococcus made by Rivolta (1873). Mycopathologia (Den Haag) 6, 135–136 (1951).Google Scholar
  38. 37.
    Conant, N. F., D. T. Smith, R. D. Baker, J. L. Callaway, and D. ST. Martin: Manual of clinical mycology, 2. edit. Philadelphia and London: W. B. Saunders Company 1954.Google Scholar
  39. 38.
    Connell, G. H., and C. E. Skinner: The origin of some species of the genus Candida in non-pseudomycelium-producing anaskosporogenous yeasts. Mycopathologia (Den Haag) 6, 65–71 (1951).Google Scholar
  40. 39.
    Connell, G. H., and C. E. Skinner: The external surface of the human body as a habitat for nonfermenting non-pigmented yeasts. J. Bact. 66, 627–633 (1953).PubMedGoogle Scholar
  41. 40.
    Connell, G. H., C. E. Skinner, and R. C. Hurd: Lipomyces starkeyi on the skin surface of the human body. Mycologia (N. Y.) 46, 12–15 (1954).Google Scholar
  42. 41.
    Costantin, M. J.: Sur les levures des animaux. Soc. Mycol. France 17, 145–148 (1901).Google Scholar
  43. 42.
    Cox, L. B., and J. C. Tolhurst: Human Torulosis, p. 149. Melbourne: University Press 1946.Google Scholar
  44. 42a.
    Crone, J. T., A. F. de Groat and J. G. Wahlin: Torula infection. Amer. J. Path. 13, 863–879 (1937).Google Scholar
  45. 43.
    Ciirtis, A. C., F. C. Boeobo, E. R. Harrell, and W. D. Block: Further studies on antifungal activity on some cinnamic acid derivatives and nitrostyrenes. Arch. Derm. Syph. (Chicago) 70, 786–798 (1954).Google Scholar
  46. 44.
    Danowski, T. S., and M. Tager: Thiourea and the inhibition of growth by fungi. J. infect. Dis. 82, 119–125 (1948).PubMedGoogle Scholar
  47. 45.
    Beurmann, L. DE, R. GouGerot: Les exascoses, endomycoses et parendomycoses (Muguet), saccharomycoses (mycose de Busse-Buschge) et parasaccharomycosezymonématoses (mycose Gilchrist). R.vision et démembrement de l’ancien groupe des blastomycoses. Trib. méd. Paris 42, 501–505, 517–524 (1909).Google Scholar
  48. 46.
    Diddens, H. A., u. J. Lodder: Die anaskosporogenen Hefen, 2. Hälfte. Amsterdam: Noord-Hollandsche Uitgevers Mantschappij 1942.Google Scholar
  49. 46a.
    Dimenna, M. E.: Cryptococcus terreus n. sp., from soil in New Zealand J gen. Microbiol. 11, 195–197 (1954).PubMedGoogle Scholar
  50. 47.
    Dodge, C. W.: Medical mycology. St. Louis: C. V. Mosby Comp. 1935.Google Scholar
  51. 48.
    Drake, C. H.: Antigenicity of Cryptococcus neoformans. Soc. Amer. Bact., Proc. 1948, p. 57.Google Scholar
  52. 49.
    Drouhet, E., et G. Segretain: Sur l’action de la lactoflavine â l’égard de Torulopsis histolytica (T. neoformans) et d’autres champignons pathogènes. C. R. Soc. Biol. (Paris) 142, 316–318 (1948).Google Scholar
  53. 50.
    Drouhet, E., et G. Segretain: Action de hyaluronidase sur la capsule de Torula histolytica. C. R. Acad. Sci. (Paris) 228, 424–425 (1949).Google Scholar
  54. 51.
    Drouhet, E., et G. Segretain: Biologie et pouvoir pathogène de torulopsis neoformans (Torula histolytica). Rev. Path. comp. 50, 37–43 (1950).Google Scholar
  55. 52.
    Drouhet, E., G. Segretain, et J. P. Aubert: Polyoside capsulaire d’un champignon pathogène Torulopsis neoformans. Relation avec la virulence. Ann. Inst. Pasteur 79, 891–900 (1950).Google Scholar
  56. 53.
    Drouhet, E., et M. Couteau: Sur les variations sectorielles des colonies de Torulopsis neoformans. Ann. Inst. Pasteur 80, 456–457 (1951).Google Scholar
  57. 54.
    Drouhet, E., et G. Segretain: Actions réciproques entre phagocytes et Torulopsis neoformans. Bull. sci. roum. Sect. Sci. méd. 1, 40–44 (1952).Google Scholar
  58. 55.
    Einbinder, J. M., RH. W. Benham, and C. T. Nelson: Chemical analysis of the capsular substance of Cryptococcus neoformans. J. invest. Derm. 22, 279–283 (1954).PubMedGoogle Scholar
  59. 56.
    Emmons, Ch.: In Henrici, Molds, yeasts and actinomycetes, 2. edit. New York and London: John Wiley & Sons 1947.Google Scholar
  60. 57.
    Emmons, Ch.: The natural occurrence in animals and soil of fungi which cause disease in man. Proc. 7. Int. Bot. Congr., Stockholm 1950, p. 416–421.Google Scholar
  61. 58.
    Emmons, Ch.: Isolation of Cryptococcus neoformans from soil. Bact. Proc. 2, 113 (1951).Google Scholar
  62. Emmons, Ch.: Isolation of Cryptococcus neoformans from soil. J. Bact. 62, 685–690 (1951).PubMedGoogle Scholar
  63. 59.
    Emmons, Ch.: Cryptococcus neoformans strains from severe outbreak of bovine mastitis. Mycopathologia (Den Haag) 6, 231–234 (1952).Google Scholar
  64. 60.
    Emmons, Ch.: The significance of saprophytism in the epidemiology of the mycoses. Trans. N. Y. Acad. Sci., Ser. II 17, 157–166 (1954).Google Scholar
  65. 61.
    Emmons, Ch.: Saprophytic sources of Cryptococcus neoformans associated with the pidgeon (Columbia livia). Amer. J. Hyg. 62, 227–232 (1955).PubMedGoogle Scholar
  66. 62.
    Evans, E. E.: An immunologic comparison of twelve strains of Cryptococcus neoformans (Torula histolytica). Proc. Soc. exp. Biol. (N. Y.) 71, 644–646 (1949).Google Scholar
  67. 63.
    Evans, E. E.: The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular and agglutination reactions. J. Immunol. 64, 423–430 (1950).PubMedGoogle Scholar
  68. 64.
    Evans, E. E., and J. W. Mehl: A qualitative analysis of capsular polysaccharides from Cryptococcus neoformans by filter paper chromatography. Science 114, 10–11 (1951).PubMedGoogle Scholar
  69. 65.
    Evans, E. E., and J. F. Kessel: The antigenic composition of Cryptococcus neoformans. II. Serologic studies with the capsular polysaccharides. J. Immunol. 67, 109–114 (1951).PubMedGoogle Scholar
  70. 66.
    Evans, E. E., and E. R. Harrell jr.: Cryptococcosis (Torulosis): A review of recent cases. Univ. Mich. med. Bull. 18, 43–63 (1952).PubMedGoogle Scholar
  71. 67.
    Evans, E. E., and R. J. Theriault: The antigenic composition of Cryptococcus neoformans IV. The use of paper chromatography for following purification of the capsular polysaccharide. J. Bact. 65, 571–577 (1953).PubMedGoogle Scholar
  72. 68.
    Evans, E. E., L. J. Sorensen and K. W. Walls: The antigenic composition of Cryptococcus neoformans. V. A survey of cross-reactions among strains of Cryptococcus and other antigens. J. Bact. 66, 287–293 (1953).PubMedGoogle Scholar
  73. 69.
    Evans, E. E., and R. F Haines: The agglutination of ion exchange resin particles coated with polysaccharide. J. Bact. 68, 130–131 (1.954).Google Scholar
  74. 70.
    Evans, E. E., H. P R Seeliger, L. Kornfeld and C. Garcia: Failure to demonstrate capsular swelling in Cryptococcus neoformans. Proc. Soc. exp. Biol. (N. Y.) 93, 257–260 (1956).Google Scholar
  75. 71.
    Fischer, J B, and N. A. Labzoffsky: Preparation of complement fixing antigen from C. neoformans. C.nad. J. Microbiol. 1, 451–454 (1955).Google Scholar
  76. 72.
    Fisher, A. M.: The clinical picture associated with infections due to Cryptococcus neoformans (Torula histolytica). Report of three cases with some experimental studies. Bull. John Hopk. Hosp. 86, 383–414 (1950).Google Scholar
  77. 73.
    Florestano, H. J., and M. E. Bahler: Antifungal properties of the polymyxins. Proc. Soc. exp. Biol. (N. Y.) 79, 141–143 (1952).Google Scholar
  78. 74.
    Foley, G. E., and L. L. Uzman: Studies on the biology of Cryptococcus. IV. Isolation of a highly polymerized polysaccharide from encapsulated strains. J. infect. Dis. 90, 38–43 (1952).PubMedGoogle Scholar
  79. 75.
    Freeman, W.: Torula meningo-encephalitis; comparative histopathology in seventeen cases. Trans. Amer. neurol. Ass. 203–217 (1930).Google Scholar
  80. 76.
    Giordano, A.: Studia micologica de Debaryomyces neoformans (Sanfelice) Redaelli, Ciferri et Giordano e significata della specie nella patologia animale. Mycopathologia (Den Haag) 1, 274–304 (1939).Google Scholar
  81. 77.
    Gold, W., H. A. Stout, J. F. Pagano, and R. Donovick: Amphothericins A and B; antifungal antibiotics produced by a streptomycete. Antibiot. Ann 1955/56, 576–586.Google Scholar
  82. 78.
    Gonzalez-Ochoa, A., L. F. Bojalil-Jaser y R. Soto Pacheco: Acciòn estimulante de las sulfonamidas–cobre y de la penicillina sobre el desarrollo de Cryptococcus neoformans y Sporotrichum schenckii, respectivamente. Rev. Soc. Mex. Hist. Nat. 11, 35–41 (1950).Google Scholar
  83. 79.
    Gonzalez-Ochoa, A., L. F. Bojalil-Jaber y R. Soto Pacheco: Actividades „in vitro“ de complejos sulfa-cotre sobre algunos hongos pathogénos. Rev. Inst. Salubr. Enferm. trop. (Méx.) 11, 79–91 (1950).Google Scholar
  84. 80.
    Gottlieb, D.: Filipin, an antibiotic inhibiting fungi. In Sternberg and Newcomer, Therapy of fungus diseases, p. 142–146. Boston and Toronto: Little, Brown & Comp. 1955.Google Scholar
  85. 81.
    Granits-Thurner, J., u. H. Schirmer: Über die Wirkung von Zimtsäurederivaten auf hautpathogene Pilze. Mykosen 1, 60–63 (1957).Google Scholar
  86. 82.
    Gridley, R. G.: A stain for fungi in tissue sections. Amer. J. clin. Path. 23, 303–307 (1953).Google Scholar
  87. 83.
    Grocott, R. G.: A stain for fungi in tissue sections and smears using Gomori’s methenamin-silver nitrate technic. Amer. J. clin. Path. 25, 975–979 (1955).Google Scholar
  88. 84.
    Grunberg, E., and R. J. Schnitzer: A chemotherapeutic study of antimonials in the experimental infection of mice with Cryptococcus neoformans. Yale J. Biol. Med. 26, 132–138 (1953).Google Scholar
  89. 85.
    Haskins, R. H., and J. A. Thorn: Biochemistry of the ustilaginales. Vii. Antibiotic activity of ustilagic acid. Canad. J. Bot. 29, 585–592 (1951).Google Scholar
  90. 86.
    Hazen, E. L., and R. Brown: Fungicidin, an antibiotic produced by a soil actinomycete. Proc. Soc. exp. Biol. (N.Y.) 76, 93–97 (1951).Google Scholar
  91. 87.
    Hehre, E. J., A. S Carlson, and D. M. Hamilton: Crystalline amylose from cultures of a pathogenic yeast (Torula histolytica). J. biol. Chem. 177, 289–293 (1949).PubMedGoogle Scholar
  92. 88.
    Hickey, R. J., C. J. Corum, P. H. Hidy, J. R. Cohen, U. F. B. Nager, and E. Kropp: Ascosin, an antifungal antibiotic produced by a streptomycete. Antibiot. and Chemother. (Basel) 2, 472–483 (1952).Google Scholar
  93. 89.
    Hirth, L., et E. Drouret: Inhibition du virus de la mosaïque du tabac par le polyoside capsulaire de Torulopsis neoformans. Ann Inst. Pasteur 84, 437–440 (1953).Google Scholar
  94. 90.
    Hobby, G. L., P. P. Regna, N. Dougherty and W. E. Stieg: The antifungal activity of antibiotic XG. J. clin. Invest. 28, 927–933 (1949).PubMedCentralGoogle Scholar
  95. 91.
    Hoff, C. L.: Immunity studies of Cryptococcus hominis (Torula histolytica) in mice. J. Lab. clin. Med. 27, 751–754 (1942).Google Scholar
  96. 92.
    Hoffmeister, W.: Die Torulopsis neoformans-Infektion. Klin Wschr. 1951, 301–307.Google Scholar
  97. 93.
    Hotchkiss, R. D.: A microchemical reaction resulting in the staining of polysaccharide structures in fixed tissue preparations. Arch. Biochem. 16, 131–141 (1948).PubMedGoogle Scholar
  98. 94.
    Johnson, C. W., J. W. Joyner and R. P. Perry: The inhibitory effect of 4 thiosemicarbazones on Cryptococcus neoformans. Antibiot. and Chemother. (Basel) 2 636–638 (1952).Google Scholar
  99. 95.
    Johnson, C. W., E. A., and K. L. Burdon: Eumycin - a new antibiotic active against pathogenic fungi and higher bacteria, including bacilli of tuberculosis and diphtheria. J. Bact. 51, 591 (1946).Google Scholar
  100. 96.
    Kaufmann, W.: Die seroiogische Differenzierung von Torulopsis neoformans und Torulopsis albida mittels der Präzipitation und Agglutination. Zbl. Bakt., II. Abt. 106, 434–437 (1944/45).Google Scholar
  101. 97.
    Keeney, E. L., L. Ajello and E. Lankford: Studies on common pathogenic fungi and on Actinomyces bovis. II. In vitro effect of sulfonamides. Bull. Johns Hopk. Hosp. 75, 393–409 (1944).Google Scholar
  102. 98.
    Kligman, A. M.: Studies of the capsular substance of Torula histolytica and the immunologic properties of Torula cells. J. Immunol. 57, 395–401 (1947).PubMedGoogle Scholar
  103. 99.
    Kligman, A. M., and F. D. Weidman: Experimental studies on treatment of human torulosis. Arch. Derm. Syph. (Chicago) 60, 726–741 (1949).Google Scholar
  104. 100.
    Kligman, A. M., and E. D. DE Lamater: The immunology of the human mycoses. Ann. Rev. Microbiol. 1950, 283–312.Google Scholar
  105. 101.
    Kligman, A. M., H. Mescon and E. D. DE Lamater: Hotchkiss-McManus-Stain for histopathologic diagnosis of fungus diseases. Amer. J. clin. Path. 21, 86–91 (1951).Google Scholar
  106. 102.
    Kligman, A. M., A. P. Crane and R. F. Norris: Effect of temperature on survival of chick embryos infected intravenously with Cryptococcus neoformans (Torula histolytica). Amer. J. med. Sci. 221, 273–278 (1951).PubMedGoogle Scholar
  107. 102a.
    Kligman, A. M., and F. S. Lewis: In vitro and in vivo activity of candicidin on pathogenic fungi. Proc. Soc. exp. Biol. (N.Y.) 82, 399–404 (1953).Google Scholar
  108. 103.
    Koch, H.: Experimentelle Untersuchungen über den Einfluß neuerer Sulfonamide auf hautpathogene und andere Pilze. Arch. klin. exp. Derm. 205, 1–21 (1957).Google Scholar
  109. 104.
    Königsbauer, H.: Experimenteller Beitrag zur Behandlung der Torulose mit D 25 (2,2-Dioxy-5,5-dichlordiphenylsulfid). Zbl. Bakt., I. Abt. Orig. 164, 466–471 (1955).Google Scholar
  110. 105.
    Kuhn, L. R.: Growth and viability of Cryptococcus hominis at mouse and rabbit body temperatures. Proc. Soc. exp. Biol. (N.Y.) 41, 573–574 (1939).Google Scholar
  111. 106.
    Kuhn, L. R.: Effect of elevated body temperatures on cryptococcosis in mice. Proc. Soc. exp. Biol. (N.Y.) 71, 341–343 (1949).Google Scholar
  112. 107.
    Landy, M., S. B. Rosenman, and G. H. Warren: An antibiotic from Bacillus subtilis active against pathogenic fungi. J. Bact. 54, 24 (1947).PubMedGoogle Scholar
  113. 108.
    Langeron, M.: Précis de mycologie. Paris: Marion 1945.Google Scholar
  114. 109.
    Larsh, H. W., ST. L. Silberg, and A. Hinton: Use of the tissue culture method in evaluating antifungal agents. Antibiot. Ann. 1956/57, 918–922.Google Scholar
  115. 110.
    Larsh, H. W., A. Hinton and ST. L. Silberg: The use of the tissue culture method in evaluating antifungal agents against systemic fungi. Antibiot. Ann. 1957/58, 988–991.Google Scholar
  116. 111.
    Littman, M. L., and L. E. Zimmerman: Cryptococcosis. New York and London: Grune & Stratton 1956.Google Scholar
  117. 112.
    Littman, M. L.: An improved method for detection of urea hydrolysis by fungi. J. infect. Dis. 101, 51–61 (1957).PubMedGoogle Scholar
  118. 113.
    Littman, M. L.: Antimycotic effect of chorquinaldol. Trans. N. Y. Acad. Sci. 18, 161–177 (1955).PubMedGoogle Scholar
  119. 114.
    Lodder, J.: Die anaskosporogenen Hefen, 1. Hälfte. Verh. Kon. Akad. Wet., Amsterdam Afd. Naturk. 32, 1–256 (1934).Google Scholar
  120. 115.
    Lodder, J.: Torulopsis or Cryptococcus. Mycopathologia (Den Haag) 1, 62–67 (1938).Google Scholar
  121. 116.
    Lodder, J., and A. DE Minjer: On the biology of the pathogenic Torulopsidoideae. In W. J. Nickerson, Biology of pathogenic fungi. Waltham, Mass.: Chronica Botanica 1947.Google Scholar
  122. 117.
    Lodder, J., and N. J. Kreger-Van Rij: The yeasts. A taxonomic study, 1, ed., p. 713. Amsterdam: North Holland Publ. Comp. 1952.Google Scholar
  123. 118.
    Ludwig, K. A., F. Y. Murray, J. K. Smith, C. R. Thompson and H. W. Werner: Laboratory studies on β-di-ethyleminoethylfencholate, a new antifungal agent. Antibiot. and Chemother. (Basel) 4, 56–61 (1954).Google Scholar
  124. 119.
    Mager, J., and M. Aschner: Starch reaction as aid in identification of causative agent of European Blastomycosis. Proc. Soc. exp. Biol. (N.Y.) 62, 71–72.Google Scholar
  125. 120.
    Mager, J., and M. Aschner: Biological studies on capsulated yeasts. J. Bact. 53, 283–295 (1947).PubMedGoogle Scholar
  126. 121.
    McManus, J. F. A.: Histological and histochemical uses of periodic acid. Stain Technol. 23, 99–108 (1948).PubMedGoogle Scholar
  127. 122.
    Mezey, C. M., and R. Fowler: Cerebrospinal cryptococcosis. J. Amer. med. Ass. 132, 632–634 (1946).Google Scholar
  128. 123.
    Miller, J M, E B. Schoenbach, P. II. Long, J. S. Schuttlework, and G. E. Snider: Treatment of infections due to Cryptococcus neoformans with stilbamidine, antibiotics and chemotherapy. Antibiot. and Chemother. (Basel) 2, 444–446 (1952).Google Scholar
  129. 124.
    Molnar, J.: Über die dichroitische Färbung der Kapsel des Cryptococcus neoformans Schweiz. Z. Path. 19, 82–87 (1956).Google Scholar
  130. 125.
    Molnar, J.: Meningo-encephalitis caused by Cryptococcus neoformans. Acta morph. Acad. Sei. hung. 6, 233–239 (1955).Google Scholar
  131. 125a.
    Mosberg jr., W. H., and J. A. Alvarez-DE Choudens: Torulosis of the central nervous System. Lancet 1951 I, 1259–1260.Google Scholar
  132. 125b.
    Mosberg jr., W. H., and J. C. Arnold jr.: Torulosis of the central nervous system. Ann. intern. Med. 32, 1153–1183 (1950).PubMedGoogle Scholar
  133. 126.
    Negroni, P., y C. Briz DE Negroni: Estudios sobre el Cryptococcus neoformans (Sanfelice). II. Aspecto micromorfologico y citologia. Ann. Soc. Ci. argent. 151, 71–76 (1951).Google Scholar
  134. 127.
    Negroni, P., y C. A. Lanata: Estudios sobre el Cryptococcus neoformans (Sanfelice). Iii. La formation capsular. Ann. Soc. Ci. argent. 113, 200–211 (1952).Google Scholar
  135. 128.
    Neill, J. M., C. G. Castillo, R. H. Smith, and CH. E. Kapros: Capsular reactions and soluble antigens of Torula histolytica and of Sporotrichum schenckii. J. exp. Med. 89, 93–106 (1949).PubMedCentralPubMedGoogle Scholar
  136. 129.
    Neill, J. M., and CH. E. Kapros: Serological tests on soluble antigens from mice infected with Cryptococcus neoformans and Sporotrichum schenckii. Proc. Soc. exp. Biol. (N. Y.) 73, 557–559 (1950).Google Scholar
  137. 130.
    Neill, J. M., I. Abrahams, and CH. E. Kapros: A comparison of the immunogenicity of weekly encpasulated and strongly encapsulated strains of Cryptococcus neoformans. J. Bact. 59, 263–275 (1950).PubMedGoogle Scholar
  138. 131.
    Neill, J. M., J. V. SuGG and D. W. McCauley: Serologically reactive material in spinal fluid, blood and urine from a human case of cryptococcosis (torulosis). Proc. Soc. exp. Biol. (N. Y.) 77, 775–778 (1951).Google Scholar
  139. 132.
    Nickerson, W. J.: Studies on film forming yeasts. Mycologia (N. Y.) 36, 224–233 (1944).Google Scholar
  140. 133.
    Nino, F. A.: Contribución al estudio de las blastomicosis en la republica argentina: Cap. V. Granuloma criptococcico. Bol. Inst. Clin. quir. Univ. B. Aires 14, 656–755 (1938).Google Scholar
  141. 134.
    Petru, M., u. M. Vojtéchovseal: Zur Frage der sog. Vaginal-Kryptokokken. Zbl. Bakt. I. Abt. Orig. 166, 218–224 (1956).Google Scholar
  142. 135.
    Pounder, W. D., J. M. Amberson and R. F. Jaeger: A severe mastitis problem associated with Cryptococcus neoformans in a large dairy herd. Amer. J. vet. Res. 13, 121–128 (1957).Google Scholar
  143. 136.
    Raper, K. B., and D. F. Alexander: Preservation of molds by the lyophil process. Micologia (N. Y.) 37, 499–525 (1945).Google Scholar
  144. 136a.
    Rappaport, B. Z., and B. Kaplan: Generalized Torula mycosis. Arch. Path. (Chicago) 1, 720–741 (1926).Google Scholar
  145. 137.
    Ratcliffe, H. E., and W. R. Cook: Cryptococcosis; review of the literature and report of a case with initial pulmonary findings. U.S. armed Forces med. J. 1, 957–969 (1950).PubMedGoogle Scholar
  146. 138.
    Redaelli, P.: Il problema della Torulopsidaceae e dei loro rapporti con l’uomo e con la pathologica umana studiato particolarmente in Italia. Vi. biol. 13, 171–235 (1931)Google Scholar
  147. 139.
    Redaelli, P., R. Ciferri e A. Giordano: Debaryomyces neoformans (Sanfelice) nobis, n. comb., pour les espèces de la groupe Saccharomyces hominis — Cryptococcus neoformans — Torula histolytica. Soz. internaz. Microbiol. Boll. sez. ital. 9, 24–28 (1937).Google Scholar
  148. 140.
    Reid, J. D.: The influence of Vitamin B complex on the growth of Torulopsis (Cryptococcus) neoformans on a synthetic medium. J. Bact. 58, 777–782 (1949).PubMedGoogle Scholar
  149. 141.
    Reilly, H. C., A. Schatz and S. A. Waksman: Antifungal properties of antibiotic substances. J. Bact. 49, 585–594 (1945).PubMedGoogle Scholar
  150. 142.
    Ribi, E., S. B. Salvin and W. R. Brown: Antigens from the yeast phase of Histoplasma capsulatum. I. Morphology of the cell as revealed by the electron microscope. Exp. Cell Res. 10, 394–404 (1956).PubMedGoogle Scholar
  151. 143.
    Rinehart, J. F., and S. K. Abdul-Haj: An improved method for histologic demonstration of acid mucopolysaccharides. Arch. Path. (Chicago) 52, 189–194 (1951).Google Scholar
  152. 144.
    Roberts, C.: Observations on the yeast Lipomyces. Nature (Lond.) 179, 1198–1199 (1957).Google Scholar
  153. 145.
    Salvin, S. B.: Quantitative studies as the serologic relationships of fungi. J. Immunol. 65, 617–626 (1950).PubMedGoogle Scholar
  154. 146.
    Salvin, S. B.: Endotoxins in pathogenic fungi. J. Immunol. 69, 89–99 (1952).PubMedGoogle Scholar
  155. 147.
    Sanfelice, F.: Über eine für Tiere pathogene SproBpilzart und über die morphologische Übereinstimmung, welche sie bei ihrem Vorkommen in den Geweben mit den vermeintlichen Krebscoccidien zeigt. Zbl. Bakt., I. Abt. Orig. 17, 113–118 (1895).Google Scholar
  156. 148.
    Sanfelice, F.: Über einen neuen pathogenen Blastomyceten, welcher innerhalb der Gewebe unter Bildung kalkartig aussehender Massen degeneriert. Zbl. Bakt., I. Abt. Orig. 18, 521–526 (1895).Google Scholar
  157. 149.
    Sanfelice, F.: Sulla azione patogena dei blastomiceti. Ann. Ist. Ig. Univ. Roma 5, 239–262 (1895).Google Scholar
  158. 150.
    Sasakawa, M.: Zur Systematik pathogener und parasitischer Hefen. Morphologisch-biochemische Studie. Zbl. Bakt., I. Orig. 88, 269–285 (1922).Google Scholar
  159. 151.
    Scherr, G. H., and R. H. Weaver: The dimorphism phenomenon in yeasts. Bact. Rev. 17, 51–92 (1933).Google Scholar
  160. 152.
    Schmidt, E. G., J. A. Alvarez-Dechoudens, N. F. McElvain, J. Beardsley and S. A. A. Tawab: A microbiological study of Cryptococcus neoformans. Arch. Biochem. 26, 15–24 (1950).Google Scholar
  161. 153.
    Schmidt, W. J.: Dichroitische Färbung tierischer und pflanzlicher Gewebe. In Handbuch der biologischen Arbeitsmethoden, Abt. V, 2/2, S. 1835. Wien: Urban & Schwarzenberg 1932.Google Scholar
  162. 154.
    Seeliger, H. P. R.: Experimentelle Untersuchungen zur mykologischen Serodiagnostik. Habil.-Schrift Bonn 1954.Google Scholar
  163. 155.
    Seeliger, H. P. R.: Zur Anwendungsmöglichkeit der Präzipitation im Agar-Gel bei der 0-Antigenanalyse von Bakterien und Pilzen. Z. Hyg. Infekt.-Kr. 141, 110–121 (1955).Google Scholar
  164. 156.
    Seeliger, H. P. R.: Ein neues Medium zur Pseudomyzelbildung von Candida albicans. Z. Hyg. Infekt.-Kr. 141, 488–494 (1955).Google Scholar
  165. 157.
    Seeliger, H. P. R.: Lungenmykosen und ihre Immunbiologie. Med. Wschr. 1954, 692–698.Google Scholar
  166. 158.
    Seeliger, H. P. R.: Mykologie und Serologie der Pneumomykosen. Tuberk.-Arzt 9, 451–463 (1955).Google Scholar
  167. 159.
    Seeliger, H. P. R.: Use of a urease test for the screening and identification of Cryptococci. J. Bact. 72, 127–131 (1956).PubMedGoogle Scholar
  168. 160.
    Seeliger, H. P. R.: Pilzbefall und Mykosen des Menschen. Röntgen-u. Lab.-Prax. 9, 192–203, 221–233 (1956).Google Scholar
  169. 161.
    Seeliger, H. P. R.: Mykologische Serodiagnostik. Leipzig: Johann Ambrosius Barth 1958.Google Scholar
  170. 162.
    Seeliger, H. P. R., u. P. Crist: Zur Schnelldiagnose der Cryptococcus-Meningitis mittels der Liquorpräzipitation. Mykosen 1, 88–92 (1958).Google Scholar
  171. 163.
    Seeliger, H. P. R.: Über die pilzhemmende Wirkung eines neuen Benzimidazolderivats. Mykosen 1, 162–171 (1958).Google Scholar
  172. 164.
    Seeliger, H. P. R.: Cryptococcose (Torulose). Mitt. der Schering-Werke 19 (1958).Google Scholar
  173. 165.
    Seeliger, H. P. R.: Unveröffentlichte Untersuchungen, 1953–1957.Google Scholar
  174. 166.
    Segretanv, G., et E. Drouhet: L’action de la streptomycine sur Torulopsis histolytica (T. neoformans) in vitro et in vivo. C. R. Soc. Biol. (Paris) 142, 319–320 (1948).Google Scholar
  175. 167.
    Segretanv, G., E. Drouhet, et F. Mariat: Essai de mise en évidence à l’état frais de la capsule d’une levure pathogène. Bull. Microscop. appl., Sér. II 2, 17–18 (1952).Google Scholar
  176. 168.
    Seneca, H., J. H. Kane and J. Rockenbach: Bactericidal, protozoicidal and fungicidal properties of thiolutin. Antibiot. and Chemother. (Basel) 2, 357–360 (1952).Google Scholar
  177. 169.
    Sheppe, W. M.: Torula infection in man. Amer. J. med. Sci. 167, 91–108 (1924).Google Scholar
  178. 169a.
    Shimwell, J. L.: A simple staining method for the detection of askospores in yeasts. J. Inst. Brewing 35, 474 (1938).Google Scholar
  179. 170.
    Siegel, M.: Fungistatic activity of methylparaben and propylparaben. Antibiot. and Chemother. (Basel) 3, 478–480 (1953).Google Scholar
  180. 171.
    Simon, J.: In vitro inhibition of mixed strains of Cryptococcus neoformans isolated from cattle. Amer. J. vet. Res. 16, 394–396 (1955).PubMedGoogle Scholar
  181. 172.
    Skinner, CH. E., CH. W. Emmons and A. M. Tsuchiya: In Henrici’s molds, yeasts and (actinomycetes, 2. edit. New York and London: John Wiley & Sons 1947.Google Scholar
  182. 173.
    Skinner, CH. E., CH. W. Emmons and A. M. Tsuchiya: Generic name for imperfect yeasts, Cryptococcus and Torulopsis. Amer. Midld. Naturalist 43, 242–250 (1950).Google Scholar
  183. 174.
    Solotorovsky, M. H., E. J. Ironson, F. J. Gregory and S. Winsten: Activity of certain diamidines against blastomycosis and Candida infections in mice. Antibiot. and Chemother. (Basel) 4, 165–168 (1954).Google Scholar
  184. 175.
    Stanley, N. F.: Polysaccharide haptens from Torula histolytica. Amer. J. exp. Biol. Med. Sci. 27, 409–415 (1949).Google Scholar
  185. 176.
    Steward, R. A., and K. F. Meyer: Isolation of C immitis (Stiles) from soil. Proc. Soc. exp. Biol. (N. Y.) 29, 937–938 (1932). Zit. nach Emmons (60).Google Scholar
  186. 177.
    Stoddard, J. L., and E. C. Cutler: Torula infection in man Monogr. Rockefeller Inst. med. Res. No 6 (1916), 98 S.Google Scholar
  187. 178.
    Symmers, W. F.: Torulosis. Lancet 1953 II, 1068–1074.Google Scholar
  188. 179.
    Tager, M., and T. S. Danowski: Inhibition of the growth of fungi by thiourea derivatives, particularly hydrazine dithiocarbamyl. J. infect. Dis. 82, 126–130 (1948).PubMedGoogle Scholar
  189. 180.
    Tager, M., A. B. Hales and T. S. Danowsxi: Studies on the suppression of fungus growth by thiourea. Iii. The effects of protein fractions, amino acids and thiol compounds. J. infect. Dis. 84, 284–289 (1949).PubMedGoogle Scholar
  190. 181.
    Thayer, J. D., W. Arson and A. J. Walker: The in vitro and in vivo effect of circulin on Cryptococcus neoformans. J. Bact. 62, 112 (1951).Google Scholar
  191. 182.
    Todd, R. L., and W. W. Hermann: The life cycle of the organism causing yeast-meningitis. J. Bact. 32, 89–102 (1936).PubMedGoogle Scholar
  192. 183.
    Tomcsik, J., and S. Guex-Holzer: Demonstration of the bacterial capsule by means of a pH-dependant salt-like combination with protein. J. gen. Microbiol. 10, 97–109 (1954).PubMedGoogle Scholar
  193. 184.
    Uzman, L. L., H. RosEN and G. E. Foley: Studies on the biology of Cryptococcus. VI. Amino acid composition of the somatic proteins of Cryptococcus neoformans. J. infect. Diss. 98, 208–210 (1956).Google Scholar
  194. 185.
    Vanbreuseghem, R.: Torulosis et Torulopsis neoformans. Ann. Soc. belge Méd. trop. 23, 495–501 (1953).Google Scholar
  195. 186.
    Verdun, P.: Précis de parasitologie humaine, parasites animaux et végétaux, les bactéries exceptées. 2. edit. Paris: V. Doin 1912.Google Scholar
  196. 187.
    Vuillemin, P.: Les blastomycètes pathogènes. Rev. gén. Sci 12, 732–751 (1901).Google Scholar
  197. 188.
    Waksman, S. A.: Outstanding problems in the study of antibacterial and antifungal antibiotics (with special reference to the antibiotics or actinomycetes). In Sternberg and Newcomer, Therapy of fungus diseases, p. 3–12. Boston and Toronto: Little, Brown & Comp. 1955.Google Scholar
  198. 189.
    Walton, R. B., and H. B. Woodruff: A crystalline antifungal agent, mycosubtilin, isolated from Subtilis broth. J. clin. Invest. 28, 924–926 (1949).PubMedCentralPubMedGoogle Scholar
  199. 190.
    Weiss, J. D.: Four pathogenic Torulae (blastomycetes). J. med. Res. 2, 280–311 (1902).Google Scholar
  200. 191.
    Whiffen, A. J., N. BonoNos and R. L. Emerson: The production of an antifungal antibiotic by Streptomyces griseus. J. Bact. 52, 610–611 (1946).PubMedGoogle Scholar
  201. 192.
    Wickerham, L. J.: A critical evaluation of the nitrogen assimilation tests commonly used in the classification of yeasts. J. Bact. 52, 293–301 (1946).Google Scholar
  202. 193.
    Wickerham, L. J., and K. A. Burton: Carbon assimilation tests for the classification of yeasts. J. Bact. 56, 363–371 (1948).PubMedGoogle Scholar
  203. 194.
    Wickerham, L. J., and M. H. Flickinger: Viability of yeasts preserved two years by the lyophil process. Brewers Digest 21, No 4 (1946).Google Scholar
  204. 195.
    Wickerham, L. J.: Recent advances in the taxonomy of yeasts. Ann. Rev. Microbiol. 6, 317–332 (1952).Google Scholar
  205. 196.
    Wilson, H. M., and A. W. Duryea: Cryptococcus meningitis (Torulosis) treated with a new antibiotic, actidione. Arch. Neurol. Psychiat. (Chicago) 66, 470–480 (1951).Google Scholar
  206. 197.
    Wolf, F. T.: Inhibition of pathogenic fungi by p-hydroxymethylbenzoate. Mycopathologia (Den Haag) 5, 117–119 (1950).Google Scholar
  207. 198.
    Wolfram, ST., u. F. Zach: Über durch niedere Pilze verursachte Nagelerkrankungen beim Menschen. Arch. Derm. Syph. (Berl.) 170, 681–694 (1934).Google Scholar
  208. 199.
    Beutmann, W.: Immunbiologische und serologische Studien an Hefen. Arch. Mikrobiol 29, 227–256 (1958).PubMedGoogle Scholar
  209. 200.
    Burcik, E., u. W. Beutmann: Zuckerbausteine wasserlöslicher Hefepolysaccharide von Haptencharakter. Naturwiss. 43, 427–428 (1956).Google Scholar
  210. 201.
    Eveland, W. C., J. D. Marshall and A. M. Silverstein: Rapid identification of pathogenic microorganisms using fluorescent antibodies of contrasting colors. Abstracts of communications, 7. Internat. Congr. for Microbiology, Stockholm, S. 313. 1958.Google Scholar
  211. 202.
    Holtz: Briefl. Mitt., Juli 1958.Google Scholar
  212. 203.
    Klatzo, I., and P. H. Geisler: Demonstration of Cryptococcus neoformans in polarized light. Stain Technol. 33, 55–56 (1958).PubMedGoogle Scholar
  213. 204.
    Staib, F.: Resistenz on Hefen und hefeartigen Pilzen gegen Schwefelsäure. Z. Hyg. Infekt.-Kr. 145, 26–33 (1958).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1959

Authors and Affiliations

  • H. P. R. Seeliger

There are no affiliations available

Personalised recommendations